Brief: Oasmia Announces Intention To Change Name To Vivesto
Jan 19 (Reuters) - Oasmia Pharmaceutical AB OASM.ST :
* OASMIA ANNOUNCES INTENTION TO CHANGE ITS NAME TO VIVESTO
* PROPOSED NAME CHANGE IS SUBJECT TO APPROVAL AT A COMPANY
EGM TO
BE HELD ON 21 FEBRUARY 2022
Source text for Eikon: ID:nMFN2SJm7
Further company coverage: OASM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on Vivesto AB
See all newsBrief: Vivesto Reports Positive Topline Results From Paccal Vet Study In Cats
Brief: Vivesto Says Topline Results For Paccal Vet 'Positive'
Brief: Vivesto Q2 Operating Loss At SEK 8.6 Mln
Brief: Vivesto: Positive Results From Exploratory Study With Cantrixil
Brief: Vivesto Appoints Björn Svanström As CFO